IDEAYA Biosciences (IDYA) Change in Receivables (2021 - 2024)
IDEAYA Biosciences (IDYA) reported Change in Receivables of -$2000.0 for Q4 2024, up 99.97% on a YoY basis from -$1000.1 in Q1 2024, and down 110.53% sequentially from $19000.0 in Q3 2024.
IDEAYA Biosciences (IDYA) Change in Receivables (2021 - 2024) Analysis & Trends
IDEAYA Biosciences (IDYA) has 4 years of Change in Receivables data on file, last reported at -$2000.0 in Q4 2024.
- For the quarter ending Q4 2024, Change in Receivables rose 99.97% year-over-year to -$2000.0; the trailing twelve-month figure through Sep 2024 stood at -$6.7 million (down 305.38% YoY), and the FY2023 full-year result was -$193000.0, up 78.36% from the prior year.
- Change in Receivables eased to -$2000.0 in Q4 2024, from $19000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $6.5 million in Q3 2023 to a low of -$6.7 million in Q4 2023.
- A 4-year average of -$116187.5 and a median of -$8500.0 in 2024 frame the typical range for Change in Receivables.
- Peak annual rise in Change in Receivables reached 1129.64% in 2022, while the deepest fall reached 3909.41% in 2022.
- Tracing IDYA's Change in Receivables over 4 years: stood at $85000.0 in 2021, then tumbled by 3909.41% to -$3.2 million in 2022, then slumped by 106.45% to -$6.7 million in 2023, then soared by 99.97% to -$2000.0 in 2024.
- Business Quant data shows IDYA's Change in Receivables at -$2000.0 in Q4 2024, $19000.0 in Q3 2024, and -$14000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | IDEAYA Biosciences | 3.21 Bn | 2.54 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Jun 30, 2024 | -14,000.00 |
| Jun 30, 2024 | -14,000.00 |
| Mar 31, 2024 | -3,000.00 |
| Mar 31, 2024 | -3,000.00 |
| Dec 31, 2023 | -6.69 Mn |
| Dec 31, 2023 | -6.69 Mn |
| Sep 30, 2023 | 6.54 Mn |
| Sep 30, 2023 | 6.54 Mn |
| Jun 30, 2023 | -308,000.00 |
| Jun 30, 2023 | -308,000.00 |
| Mar 31, 2023 | 257,000.00 |
| Mar 31, 2023 | 257,000.00 |
| Dec 31, 2022 | -3.24 Mn |
| Dec 31, 2022 | -3.24 Mn |
| Sep 30, 2022 | 3.16 Mn |
| Sep 30, 2022 | 3.16 Mn |